Associated Banc-Corp’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.96M Buy
77,631
+8,094
+12% +$204K 0.05% 173
2026
Q1
$1.76M Buy
69,537
+8,656
+14% +$221K 0.05% 174
2025
Q4
$1.55M Buy
60,881
+15,083
+33% +$386K 0.04% 183
2025
Q3
$1.17M Buy
45,798
+4,859
+12% +$123K 0.03% 197
2025
Q2
$1.04M Buy
40,939
+3,889
+10% +$96.5K 0.03% 201
2025
Q1
$926K Buy
37,050
+1,250
+3% +$30.9K 0.03% 206
2024
Q4
$880K Buy
35,800
+8,100
+29% +$203K 0.03% 207
2024
Q3
$712K Buy
27,700
+1,500
+6% +$37.9K 0.02% 221
2024
Q2
$643K Buy
26,200
+6,450
+33% +$158K 0.02% 222
2024
Q1
$490K Buy
+19,750
New +$489K 0.02% 235

Other funds holding IBDX

Associated Banc-Corp's IBDX Position: Q2 2026 in Review

Associated Banc-Corp increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 12% in Q2 2026, buying an estimated $204K and bringing the position to 77,631 shares worth $1.96M. The position accounts for 0.05% of the portfolio, ranked #173.

Associated Banc-Corp first reported a position in IBDX in Q1 2024 and has held it in 10 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Associated Banc-Corp held 77,631 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $1.96M as of Q2 2026.
  • Associated Banc-Corp bought 8,094 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $204K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.05% of Associated Banc-Corp's portfolio in Q2 2026, its #173 holding.
  • Associated Banc-Corp first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q1 2024 and has held it in 10 quarters since.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Associated Banc-Corp's 13F filing for Q2 2026, filed 31 Jul 2026.